Health Canada drug identification number

DIN 02469898 — ADMELOG 100 UNIT

ADMELOG is a solution of Insulin Lispro marketed by SANOFI-AVENTIS CANADA INC. The full Insulin Lispro monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02469898
Brand name
ADMELOG
Active ingredient
Insulin Lispro
Strength
100 UNIT
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Manufacturer
SANOFI-AVENTIS CANADA INC
Health Canada status
MARKETED
Drug class
Rapid-acting insulin analogue (anti-diabetic agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Insulin Lispro products

DINBrandStrengthFormManufacturerStatus
02469901 ADMELOG 100 UNIT SOLUTION SANOFI-AVENTIS CANADA INC MARKETED
02469871 ADMELOG SOLOSTAR 100 UNIT SOLUTION SANOFI-AVENTIS CANADA INC MARKETED
02229704 HUMALOG 100 UNIT SOLUTION ELI LILLY CANADA INC MARKETED
02470152 HUMALOG 100 UNIT SOLUTION ELI LILLY CANADA INC MARKETED
02229705 HUMALOG (CARTRIDGE) 100 UNIT SOLUTION ELI LILLY CANADA INC MARKETED
02403412 HUMALOG (KWIKPEN) 100 UNIT SOLUTION ELI LILLY CANADA INC MARKETED
02439611 HUMALOG 200 UNITS/ML KWIKPEN 200 UNIT SOLUTION ELI LILLY CANADA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.